“…The results are comparable with an American study that reported use of warfarin by 42% of patients with AF at high risk of stroke, and by 44% of patients with moderate stroke risk. 12 Aspirin significantly reduces the risk of stroke in patients who experienced a transient ischaemic attack (TIA) or stroke, 13 and should be given as soon as possible after onset and continued as long-term antiplatelet therapy. 14 Our analysis showed that an increasing number of patients were receiving aspirin as a monotherapy after a TIA or ischaemic stroke event, reaching around one-quarter of the at-risk group in March 2010.…”
“…The results are comparable with an American study that reported use of warfarin by 42% of patients with AF at high risk of stroke, and by 44% of patients with moderate stroke risk. 12 Aspirin significantly reduces the risk of stroke in patients who experienced a transient ischaemic attack (TIA) or stroke, 13 and should be given as soon as possible after onset and continued as long-term antiplatelet therapy. 14 Our analysis showed that an increasing number of patients were receiving aspirin as a monotherapy after a TIA or ischaemic stroke event, reaching around one-quarter of the at-risk group in March 2010.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.